$GOSS
Gossamer Bio, Inc. Common Stock
XNAS
Why is GOSS down today? It is at $0.176 (-0.76%), and our scanner flagged it 157 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GOSS spikes, and full due diligence on GOSS — key stats, earnings, dilution and insider activity. Free.
Get free $GOSS alerts the moment volume spikes
Our scanner flagged $GOSS 157 times in the last 30 days. Create a free account to track $GOSS, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $0.176
- Change today
- -0.76%
- Previous close
- $0.178
- 52-week range
- $0.114 – $3.87
- Market cap
- $42M
- Institutional own.
- 45.72%
- Total held
- 45.7%
- Tradeable float
- 127.4M 54% of shares · after 46% institutions
- Short interest
- 73.2M ▲ +36% vs prior · as of 2026-07-15
- Short % of float
- 57.4%
- Days to cover
- 3.8d
- Avg daily volume
- 12.4M
- Exchange
- XNAS
- 5m
- 0.2x
- 15m
- 0.2x
- 1h
- 0.2x
- 1D
- 0.0x
Get free GOSS + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $GOSS down today?
Here is the latest on GOSS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GOSS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystGossamer Bio Announces FDA Regulatory Update and Reacquisition of Worldwide Rights Related to Seralutinib and Provides a Business UpdateReported The Company held a Pre-NDA Type B meeting with the FDA in mid-June 2026 and has since received the official meeting minutes.Reported The Company plans to submit the NDA for seralutinib in PAH in September 2026. If accepted for filing, seralutinib could be eligible for an FDA approval decision in the third quarter of 2027.Reported The Company expects to effect the reverse stock split in or promptly following the third quarter of 2026, with the timing and final ratio being subject to final Board action., from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
0 buys, 0 sells last 3 months (13/0 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Christian Waage Officer | Acquired (grant/award) | +85K 0.04% of company | added 12% | 814K | n/a | Jan 2, 26 |
Peterson Caryn Officer | Acquired (grant/award) | +85K 0.04% of company | added 48% | 259K | n/a | Jan 2, 26 |
Aranda Richard Officer | Acquired (grant/award) | +94K 0.04% of company | added 25% | 463K | n/a | Jan 2, 26 |
Smith Robert Paul Jr Officer | Acquired (grant/award) | +94K 0.04% of company | added 56% | 261K | n/a | Jan 2, 26 |
Giraudo Bryan Officer | Acquired (grant/award) | +116K 0.05% of company | added 42% | 390K | n/a | Jan 2, 26 |
Hasnain Faheem Officer | Acquired (grant/award) | +280K 0.1% of company | added 50% | 838K | n/a | Jan 2, 26 |
Peterson Caryn Officer | Acquired (grant/award) | +125K 0.05% of company | added 100% | 175K | n/a | Oct 1, 25 |
Hasnain Faheem Officer | Acquired (grant/award) | +438K 0.2% of company | added 100% | 558K | n/a | Oct 1, 25 |
Giraudo Bryan Officer | Acquired (grant/award) | +181K 0.08% of company | added 100% | 274K | n/a | Oct 1, 25 |
Christian Waage Officer | Acquired (grant/award) | +125K 0.05% of company | added 21% | 711K | n/a | Oct 1, 25 |
Aranda Richard Officer | Acquired (grant/award) | +163K 0.07% of company | added 79% | 369K | n/a | Oct 1, 25 |
Smith Robert Paul Jr Officer | Acquired (grant/award) | +163K 0.07% of company | n/a | 163K | n/a | Oct 1, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
$GOSS Sentiment
BearishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$GOSS Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
GOSS stock FAQ
Why is $GOSS down today?
Here is the latest on GOSS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GOSS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the GOSS stock price today?
GOSS last traded at $0.176, down 0.76% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live GOSS alerts?
The GOSS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GOSS 157 times in the last 30 days.
What exchange is GOSS on?
GOSS (Gossamer Bio, Inc. Common Stock) trades on XNAS, with a market cap of about $42M.
Is GOSS good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GOSS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.